Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AIMT - Aimmune down 5% on FDA timeline for AR101

AIMT - Aimmune down 5% on FDA timeline for AR101

Aimmune Therapeutics Inc.
  • Aimmune Therapeutics (AIMT -4.8%) is down on below-average volume in reaction to the FDA's review period for AR101 for peanut allergy.
  • More news on: Aimmune Therapeutics, Inc., Healthcare stocks news, Stocks on the move,
    • Read more ...
Stock Information
Company Name: Aimmune Therapeutics Inc.
Stock Symbol: AIMT
Market: NASDAQ
Website: aimmune.com
Menu
AIMT AIMT Quote AIMT Short AIMT News AIMT Articles AIMT Message Board
Get AIMT Alerts

News, Short Squeeze, Breakout and More Instantly...